Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.510
-0.130 (-7.91%)
Aug 14, 2025, 11:26 AM - Market open
Traws Pharma Employees
As of December 31, 2024, Traws Pharma had 7 total employees, including 6 full-time and 1 part-time employees. The number of employees decreased by 11 or -61.11% compared to the previous year.
Employees
7
Change (1Y)
-11
Growth (1Y)
-61.11%
Revenue / Employee
$32,429
Profits / Employee
-$4,944,000
Market Cap
8.40M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TRAW News
- 4 hours ago - Traws Pharma Reports Second Quarter 2025 Results and Business Highlights - GlobeNewsWire
- 6 days ago - Traws Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025 - GlobeNewsWire
- 6 weeks ago - Traws Pharma Advances Antiviral Pipeline with Multiple Regulatory Submissions - GlobeNewsWire
- 2 months ago - Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib - GlobeNewsWire
- 2 months ago - Traws Pharma Announces Receipt of FDA Guidance on Tivoxavir Marboxil and Reports Plans for Pursuing Stockpiling for Pandemic Preparedness - GlobeNewsWire
- 3 months ago - Traws Pharma Reports First Quarter 2025 Results and Business Highlights - GlobeNewsWire
- 4 months ago - Traws Pharma, Inc. (TRAW) Virtual Investor Event Transcript - Seeking Alpha
- 4 months ago - Traws Pharma Announces Management Updates - GlobeNewsWire